Background: Cervical cancer is the fourth common cancer in women worldwide. The Papanicolau test is the primary screening procedure to detect abnormal cervical cells. Colposcopy is the main procedure for discriminating high-grade cervical lesions. The study aimed at clarifying the discrepancy between cervical cytology and colposcopic biopsy histology as well as confounding factors. Methods: Eligible patients visited thirteen tertiary hospitals for colposcopic biopsy following cervical cytology and human papillomavirus (HPV) genotypes between January and December 2018. Baseline characteristics including age, body mass index (BMI), and parity were collected. Results: In our study, 3,798 eligible patients were included. Mean age of patients ...
Objective: Persistent infection with human papillomavirus (HPV) is recognized as the main risk facto...
Objectives: Discrepancies between abnormal cervical cytology or high-risk human papillomavirus (HR-H...
Background: Cervical cancer is the fourth most frequent cancer globally in women with an estimated 5...
Objective: The aim of the study was to determine whether p16 positive/cervical intraepithelial neopl...
This study aimed to compare the colposcopic biopsy results of patients with negative cervical cytolo...
Australia's new HPV-based cervical screening program is based on an algorithm that incorporates refl...
Background: Cervical cancer in women is the second most common cancer and the commonest cause of mor...
CONTEXT: Cervical cytology continues to be the most appropriate method for investigating cervical ne...
Although cytology‐based screening programs have significantly reduced mortality and morbidity from c...
Objective: To investigate the risk of developing cervical intraepithelial neoplasia grade 2 (CIN2) o...
Background—HPV testing is more sensitive than cytology; some cervical cancer prevention programs wil...
Background: Cervical cancer is the fourth most common cancer among women, accounting for 10% of all ...
Objective: Persistent infection with human papillomavirus (HPV) is recognized as the main risk facto...
Aim: In patients with high-risk human papilloma virus (HPV), there is no consensus on the inclu...
Aim: In patients with high-risk human papilloma virus (HPV), there is no consensus on the inclu...
Objective: Persistent infection with human papillomavirus (HPV) is recognized as the main risk facto...
Objectives: Discrepancies between abnormal cervical cytology or high-risk human papillomavirus (HR-H...
Background: Cervical cancer is the fourth most frequent cancer globally in women with an estimated 5...
Objective: The aim of the study was to determine whether p16 positive/cervical intraepithelial neopl...
This study aimed to compare the colposcopic biopsy results of patients with negative cervical cytolo...
Australia's new HPV-based cervical screening program is based on an algorithm that incorporates refl...
Background: Cervical cancer in women is the second most common cancer and the commonest cause of mor...
CONTEXT: Cervical cytology continues to be the most appropriate method for investigating cervical ne...
Although cytology‐based screening programs have significantly reduced mortality and morbidity from c...
Objective: To investigate the risk of developing cervical intraepithelial neoplasia grade 2 (CIN2) o...
Background—HPV testing is more sensitive than cytology; some cervical cancer prevention programs wil...
Background: Cervical cancer is the fourth most common cancer among women, accounting for 10% of all ...
Objective: Persistent infection with human papillomavirus (HPV) is recognized as the main risk facto...
Aim: In patients with high-risk human papilloma virus (HPV), there is no consensus on the inclu...
Aim: In patients with high-risk human papilloma virus (HPV), there is no consensus on the inclu...
Objective: Persistent infection with human papillomavirus (HPV) is recognized as the main risk facto...
Objectives: Discrepancies between abnormal cervical cytology or high-risk human papillomavirus (HR-H...
Background: Cervical cancer is the fourth most frequent cancer globally in women with an estimated 5...